About Omnipod® Products

The Omnipod® 5 Automated Insulin Delivery System and the Omnipod DASH® Insulin Management System

Omnipod® combines a small, tubeless, waterproof*, wearable device (the Pod) with a handheld device, the Personal Diabetes Manager (PDM), also called a Controller. Fill the Pod with insulin and it can be worn directly on the body. The Pod communicates wirelessly† with the PDM/Controller to program insulin delivery.

Whether your patient is newly diagnosed with diabetes, currently receives daily insulin injections, or is considering a switch from another insulin pump, one of our Omnipod products may be the right insulin management option.

†At start-up, the Pod and PDM/Controller must be adjacent and touching. During normal operation, the PDM/Controller must be
within 1.5 metres of the Pod.
*The Pod has a waterproof IP28 rating for up to 7.6 metres (25 feet) for 60 minutes. The PDM/Controller is not waterproof.

Introducing Omnipod® 5 Automated Insulin Delivery System

Omnipod 5 Omnipod 5
Screen image is an example, for illustrative purposes only. Pod shown without the necessary adhesive. * Sensors are sold separately and require a separate prescription.
  • The first and only tubeless automated insulin delivery (AID) system compatible with with Dexcom G6 and G7
  • Built-in SmartAdjust™ technology adjusts basal insulin so you don’t have to and helps to correct highs and protect from lows1-3
  • Customisable glucose targets can accommodate your patients’ routines
  • SmartBolus calculator is informed with sensor value and trend for bolus recommendations
Omnipod® 5 AID System

Introducing Omnipod DASH® Insulin Management System

Omnipod 5 Omnipod 5
  • Pod therapy may help simplify life for your patients with type 1 diabetes, by providing an alternative to Multiple Daily Injections (MDI)
  • It’s tubeless, waterproofΩ and wearable
  • Set a Zero Basal Rate for time when low insulin delivery is needed
  • Set Fractional Insulin to Carb Ratios (0.1g/U) for insulin sensitivity
  • Set various presets to establish favourites, tag activities and personalise insulin delivery based on daily routine
Omnipod DASH® System
ΩThe Pod has an IP28 rating for up to 7.6 metres (25 feet) for up to 60 minutes. The PDM is not waterproof.

1. In Automated Mode, SmartAdjust technology uses your total daily insulin (TDI) to set a new Adaptive Basal Rate for you.

2. Brown S. et al. Diabetes Care. 2021;44:1630-1640. Prospective pivotal trial in 240 participants with T1D aged 6 - 70 yrs. Study included a 14-day standard therapy (ST) phase followed by a 3-month Omnipod 5 hybrid closed-loop (HCL) phase. Mean time in hyperglycaemic range (>10.0 mmol/L or >180mg/dL) as measured by CGM in adults/adolescents and children ST vs. 3-mo Omnipod 5: 28.9% vs. 22.8%; 44.8% vs 29.7%, P<0.0001, respectively. Mean time in hypoglycaemic range (<3.9 mmol/L or <70 mg/dL) as measured by CGM in adults/adolescents and children ST vs. 3-mo Omnipod 5: 2.89% vs. 1.32%, P<0.0001; 2.21% vs. 1.78, P=0.8153, respectively. Study funded by Insulet.

3. Sherr J. et al. Diabetes Care. 2022; 45:1907-1910. Single-arm multicenter clinical trial in 80 pre-school children (aged 2- 5.9 yrs) with T1D. Study included a 14-day standard therapy (ST) phase followed by a 3-month AID phase with Omnipod 5 system. Mean time in hyperglycaemic range (>10.0 mmol/L or >180mg/dL) as measured by CGM in children ST vs. 3-mo Omnipod 5: 39.4% vs. 29.5%, P<0.0001, respectively. Mean time in hypoglycaemic range (<3.9 mmol/L or <70 mg/dL) as measured by CGM in children ST vs. 3-mo Omnipod 5: 3.43% vs. 2.46%, P=0.0204. Study funded by Insulet.